Učitavanje...
Safety and efficacy of tislelizumab plus chemotherapy for first‐line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma
Spremljeno u:
| Izdano u: | Thorac Cancer |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons Australia, Ltd
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7705902/ https://ncbi.nlm.nih.gov/pubmed/33043992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13690 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|